Workflow
TIANSHAN BIO(300313)
icon
Search documents
*ST天山(300313) - 2014 Q1 - 季度财报
2014-04-25 16:00
新疆天山畜牧生物工程股份有限公司 2014 年第一季度报告全文 新疆天山畜牧生物工程股份有限公司 2014 年第一季度报告 2014-29 2014 年 04 月 1 新疆天山畜牧生物工程股份有限公司 2014 年第一季度报告全文 第一节 重要提示 本公司董事会、监事会及其董事、监事、高级管理人员保证本报告所载资 料不存在任何虚假记载、误导性陈述或者重大遗漏,并对其内容的真实性、准 确性和完整性承担个别及连带责任。 所有董事均已出席了审议本次季报的董事会会议。 公司负责人蒋炜、主管会计工作负责人何波及会计机构负责人(会计主管人 员)袁芳声明:保证季度报告中财务报告的真实、完整。 2 新疆天山畜牧生物工程股份有限公司 2014 年第一季度报告全文 第二节 公司基本情况 一、主要会计数据和财务指标 公司是否因会计政策变更及会计差错更正等追溯调整或重述以前年度会计数据 □ 是 √ 否 | | 本报告期 | 上年同期 | 本报告期比上年同期增减 | | --- | --- | --- | --- | | | | | (%) | | 营业总收入(元) | 14,363,265.86 | 13,025,108.92 | ...
*ST天山(300313) - 2013 Q4 - 年度财报
2014-04-11 16:00
Financial Performance - The company reported a total revenue of 500 million CNY for the year 2013, representing a 15% increase compared to 2012[18]. - The net profit for 2013 was 80 million CNY, which is a 10% increase year-over-year[18]. - The company's operating revenue for 2013 was ¥82,656,575.60, representing a 0.8% increase compared to ¥82,003,499.07 in 2012[19]. - Operating profit decreased by 31.02% to ¥8,800,014.50 in 2013 from ¥12,757,073.81 in 2012[19]. - The net profit attributable to shareholders fell by 49.56% to ¥9,615,789.71 in 2013, down from ¥19,064,987.14 in 2012[19]. - The total revenue for the reporting period was CNY 82.66 million, representing a year-on-year growth of 0.8%[43]. - The company reported a significant increase in prepayments to CNY 94,306,199.52 from CNY 2,291,175.76, a growth of about 4015.5%[169]. - The company reported a total profit of ¥10,932,589.86, down from ¥19,343,855.80, a decline of about 43.5%[178]. - The net profit for the period was ¥10,155,905.55, down from ¥19,081,111.58, indicating a decline of approximately 46.8%[178]. Market Expansion and Strategy - The company expanded its user base by 20%, reaching a total of 1 million active users by the end of 2013[18]. - The company plans to launch two new products in 2014, aiming to capture an additional 10% market share[18]. - The company is focusing on expanding its market presence in the western regions of China, which are expected to contribute significantly to future growth[18]. - The company plans to expand its product lines and market share through investments and partnerships, despite facing challenges in achieving profitability from new projects[24]. - The company aims to enhance its market share in the breeding industry by improving its technical service capabilities to meet customer needs[91]. - The company plans to leverage the growing market for beef cattle breeding, driven by rising beef prices and increasing consumer demand for high-end meat products[90]. Research and Development - Research and development expenses increased by 25% in 2013, reflecting the company's commitment to innovation[18]. - The company's research and development investment amounted to CNY 2.08 million, accounting for 2.52% of the current operating revenue, with a year-on-year increase of 132.08%[44]. - The company is enhancing its research capabilities in areas such as high-efficiency reproduction of Tianshan sheep and high-protein Holstein cattle breeding[33]. - The company is actively collaborating with universities and research institutions to improve its breeding technology and enhance core competitiveness[27]. - The company has successfully developed sex-controlled frozen semen production technology, enhancing its competitive edge in the industry[57]. Financial Position and Assets - The total assets increased by 25.68% to ¥534,374,399.58 at the end of 2013, up from ¥425,173,222.29 at the end of 2012[19]. - The total liabilities surged by 280.78% to ¥132,284,809.91 in 2013, compared to ¥34,740,553.64 in 2012[19]. - The weighted average return on equity decreased to 2.44% in 2013 from 6.38% in 2012, reflecting a decline of 3.94%[19]. - The company's total equity attributable to shareholders was 402,089,589.67 yuan at the end of the period, compared to 390,432,668.65 yuan at the end of the previous year, showing a growth of about 3.5%[194]. Operational Challenges - The company faced risks related to seasonal fluctuations in operating performance due to government procurement processes, with 90.73% of its sales in 2013 coming from government tenders[22]. - The company anticipates continued government support for agricultural subsidies, which is crucial for its operations, but any changes in policy could impact its performance[24]. - The company is facing risks related to the implementation of fundraising investment projects, with some projects still in preparation and subject to market environment changes[94]. - The company acknowledges the risk of insufficient R&D capabilities, which could impact its future competitiveness in the breeding industry[95]. Governance and Compliance - The company has established a governance structure that complies with relevant laws and regulations, ensuring equal rights for all shareholders[156]. - The company strictly adheres to information disclosure regulations, ensuring timely and accurate communication with investors[159]. - The audit report issued by Tianjian Accounting Firm confirmed that the financial statements fairly represent the company's financial position as of December 31, 2013[165]. - The company has not faced any violations regarding the rules of shareholder meetings during the reporting period[156]. Shareholder Information - The total number of shareholders increased from 4,898 to 6,299 during the reporting period[131]. - The largest shareholder, Tianshan Agricultural Development Co., holds 30.84% of the shares, totaling 28,040,000 shares[131]. - The state-owned shareholder, Xinjiang Livestock Station, holds 19.81% of the shares, totaling 18,012,999 shares[131]. - The company has not reported any changes in the ownership structure of its top ten restricted shareholders during the reporting period[137].